| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |